港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

石药集团

9.370

+0.0500.54%

成交量：1.16亿

成交额：10.78亿

市值：1,079.61亿

市盈率：23.31

高：9.430

开：9.320

低：9.150

收：9.320

52周最高：11.630

52周最低：4.215

股本：115.22亿

香港流通股本：115.22亿

量比：0.72

换手率：1.00%

股息：0.26

股息率：2.77%

每股收益(LYR):0.402

净资产收益率：10.83%

总资产收益率：5.65%

市净率：2.98

市盈率(LYR):23.31

市销率: 3.81

数据加载中...

总览公司新闻公告

石药集团(01093)：石药创新建议于联交所主板上市

石药创新拟11亿元收购巨石生物29%股权

石药集团(01093)：SYH2070注射液(双链小干扰RNA药物)在中国获临床试验批准

《大行》瑞银降石药(01093.HK)和科伦药业(002422.SZ)至“中性”行业首选改为翰森制药(03692.HK)

阿斯达克财经

大健康行业周报 |13亿，“中国美敦力”完成交割；东星医疗：拟以支付现金方式购买武汉医佳宝90%的股权

华源证券-医药行业周报信立泰：全面布局CKM管线，创新出海加速推进-250928

石药在谋变

石药集团加速蜕变

开源证券：小核酸药物有望成为减重赛道新风口联用GLP-1或多重满足临床需求

【券商聚焦】交银国际：政策端持续释放利好信号医药行业格局优化趋势明确

石药进军AD百亿蓝海，直指卫材/渤健！恒瑞、先声等群雄逐鹿

医药经济报

石药集团(01093)：仑卡奈单抗注射液在中国获临床试验批准

东吴证券：MNC纷纷下注小核酸领域中国企业有望抢占全球蓝海市场

中邮·医药|周观点：基药目录调整工作有望继续推进，关注中药品种调增机会

中邮证券研究所

石药集团美洛昔康纳晶注射液破局而生

年内收益率翻倍基金达40只：都有哪些产品？买了啥？

每日卖空追踪 | 石药集团 09月22日卖空量成交946.8万股，卖空比例为7.58%

石药集团09月22日主力净流入5654.5万元散户资金抛售

医药生物行业点评报告：集采优化叠加创新驱动，Pharma迎来发展新阶段

丁苯酞市场风云：石药创新领航，复星等企业突围前景几何？

摩熵医药大数据

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/01093/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01093","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01093\",,,,,undefined,":{"symbol":"01093","market":"HK","secType":"STK","nameCN":"石药集团","latestPrice":9.37,"timestamp":1759219684003,"preClose":9.32,"halted":0,"volume":115713376,"delay":0,"floatShares":11522000000,"shares":11522000000,"eps":0.40202000627232476,"marketStatus":"国庆日休市","change":0.05,"latestTime":"09-30 16:08:04","open":9.32,"high":9.43,"low":9.15,"amount":1078294848,"amplitude":0.030043,"askPrice":9.38,"askSize":300000,"bidPrice":9.37,"bidSize":444000,"shortable":3,"etf":0,"ttmEps":0.36442582910638827,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1759368600000},"marketStatusCode":7,"adr":0,"listingDate":772128000000,"exchange":"SEHK","adjPreClose":9.32,"dividendRate":0.027748,"openAndCloseTimeList":[[1759195800000,1759204800000],[1759208400000,1759219200000]],"volumeRatio":0.7248207372236094,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"CSP.HK","impliedVol":0.5644,"impliedVolPercentile":0.6235},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01093\",,,,,undefined,":{"symbol":"01093","floatShares":11522000000,"roa":"5.65%","roe":"10.83%","lyrEps":0.40202,"volumeRatio":0.7248207372236094,"shares":11522000000,"dividePrice":0.26,"high":9.43,"amplitude":0.030043,"preClose":9.32,"low":9.15,"week52Low":4.215,"pbRate":"2.98","psRate":"3.81","week52High":11.63,"institutionHeld":0,"latestPrice":9.37,"committee":0.193548,"eps":0.40202000627232476,"divideRate":0.027748,"volume":115713376,"delay":0,"ttmEps":0.36442582910638827,"open":9.32,"prevYearClose":4.719,"prevWeekClose":9.09,"prevMonthClose":9.37,"prevQuarterClose":9.37,"fiveDayClose":9.47,"twentyDayClose":10.75,"sixtyDayClose":7.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01093\",params:#limit:5,,,undefined,":[{"date":"2025-10-17","symbol":"01093","amount":0.14,"announcedDate":"2025-08-22","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-10-20","defaultRemindTime":1760664600000,"name":"石药集团","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-18","payableDate":"2025-10-20","currency":"HKD","dateTimestamp":1760630400000,"payDate":"2025-11-18"},{"date":"2025-08-22","symbol":"01093","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755826200000,"name":null,"time":"","dateTimestamp":1755792000000,"actualEps":null},{"date":"2025-06-04","symbol":"01093","amount":0.1,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-06-05","defaultRemindTime":1749000600000,"name":"石药集团","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-18","payableDate":"2025-06-05","currency":"HKD","dateTimestamp":1748966400000,"payDate":"2025-07-18"},{"date":"2025-05-29","symbol":"01093","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1748482200000,"name":null,"time":"","dateTimestamp":1748448000000,"actualEps":null},{"date":"2025-03-28","symbol":"01093","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"","dateTimestamp":1743091200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01093\",market:\"HK\",,,undefined,":[{"executeDate":"2016-06-02","recordDate":"2016-06-03","paymentDate":"2016-06-17","value":0.11,"currency":"HKD"},{"executeDate":"2017-05-31","recordDate":"2017-06-01","paymentDate":"2017-06-15","value":0.12,"currency":"HKD"},{"executeDate":"2018-05-30","recordDate":"2018-05-31","paymentDate":"2018-06-15","value":0.15,"currency":"HKD"},{"executeDate":"2019-05-30","recordDate":"2019-05-31","paymentDate":"2019-06-14","value":0.18,"currency":"HKD"},{"executeDate":"2020-06-18","recordDate":"2020-06-19","paymentDate":"2020-07-03","value":0.2,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01093\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2308,"buy":0.4231,"hold":0.2692,"sell":0.0385,"strongSell":0.0385,"meanLabel":"BUY","meanPercent":0.4231,"analysts":26,"updateTime":1756224000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01093\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01093","date":"2025-09-30","current":25.705958,"percent":0.972292,"low":8.203564,"twenty":10.917922,"median":14.078162,"eighty":18.693874,"high":31.145195,"avg":14.928366,"sd":4.321168,"marketCap":107127443612},"quantilePoints":[{"date":"2020-10-09","current":24.354821,"twenty":23.823147,"median":25.674577,"eighty":27.763078,"marketCap":117005351251},{"date":"2020-10-16","current":22.902308,"twenty":23.823147,"median":25.599272,"eighty":27.734046,"marketCap":109982041534},{"date":"2020-10-23","current":21.226413,"twenty":23.697501,"median":25.502111,"eighty":27.702089,"marketCap":102092025511},{"date":"2020-10-30","current":20.303632,"twenty":23.681634,"median":25.422577,"eighty":27.680206,"marketCap":97668834710},{"date":"2020-11-06","current":20.290055,"twenty":23.571048,"median":25.359117,"eighty":27.663174,"marketCap":98744745986},{"date":"2020-11-13","current":20.444832,"twenty":23.42362,"median":25.25367,"eighty":27.642614,"marketCap":99581565867},{"date":"2020-11-20","current":19.951558,"twenty":23.328317,"median":25.072825,"eighty":27.627001,"marketCap":97788380407},{"date":"2020-11-27","current":17.555385,"twenty":23.124977,"median":24.987062,"eighty":27.622015,"marketCap":91452458449},{"date":"2020-12-04","current":17.771736,"twenty":22.883092,"median":24.933822,"eighty":27.5931,"marketCap":93245643909},{"date":"2020-12-11","current":16.352669,"twenty":22.646911,"median":24.873341,"eighty":27.566679,"marketCap":85594719281},{"date":"2020-12-18","current":17.876734,"twenty":22.313213,"median":24.838038,"eighty":27.539563,"marketCap":93723826698},{"date":"2020-12-24","current":17.311631,"twenty":22.161704,"median":24.804166,"eighty":27.514969,"marketCap":90854729963},{"date":"2020-12-31","current":18.055922,"twenty":22.085041,"median":24.730756,"eighty":27.495797,"marketCap":94799737974},{"date":"2021-01-08","current":18.391217,"twenty":17.81562,"median":17.981235,"eighty":18.209833,"marketCap":97429743315},{"date":"2021-01-15","current":18.055783,"twenty":17.901312,"median":18.097327,"eighty":18.303438,"marketCap":95517012158},{"date":"2021-01-22","current":19.442442,"twenty":17.967746,"median":18.141868,"eighty":18.690831,"marketCap":102809299695},{"date":"2021-01-29","current":17.75832,"twenty":17.967746,"median":18.257642,"eighty":19.03945,"marketCap":94680192277},{"date":"2021-02-05","current":18.361589,"twenty":17.993149,"median":18.316487,"eighty":19.15147,"marketCap":97310197618},{"date":"2021-02-11","current":18.515502,"twenty":18.022968,"median":18.316487,"eighty":19.07305,"marketCap":98266563197},{"date":"2021-02-19","current":19.453063,"twenty":18.055811,"median":18.36697,"eighty":19.106651,"marketCap":103287482484},{"date":"2021-02-26","current":18.277419,"twenty":18.072484,"median":18.384355,"eighty":19.106651,"marketCap":96832014829},{"date":"2021-03-05","current":18.730538,"twenty":18.139358,"median":18.461275,"eighty":19.106651,"marketCap":98983837380},{"date":"2021-03-12","current":21.550702,"twenty":18.153021,"median":18.599893,"eighty":19.248334,"marketCap":113687958151},{"date":"2021-03-19","current":18.743553,"twenty":18.202217,"median":18.618332,"eighty":19.243565,"marketCap":115361597913},{"date":"2021-03-26","current":17.753644,"twenty":18.072484,"median":18.5499,"eighty":19.199892,"marketCap":108786584561},{"date":"2021-04-01","current":18.367582,"twenty":18.055922,"median":18.471915,"eighty":19.168298,"marketCap":112253409783},{"date":"2021-04-09","current":18.522307,"twenty":18.105607,"median":18.515502,"eighty":19.15147,"marketCap":113448866756},{"date":"2021-04-16","current":18.646882,"twenty":18.105607,"median":18.518905,"eighty":19.049237,"marketCap":114644323729},{"date":"2021-04-23","current":19.240379,"twenty":18.140613,"median":18.577507,"eighty":19.049237,"marketCap":118589331741},{"date":"2021-04-30","current":18.581916,"twenty":18.146156,"median":18.593834,"eighty":18.978773,"marketCap":115002960821},{"date":"2021-05-07","current":18.231992,"twenty":18.178187,"median":18.581916,"eighty":18.969246,"marketCap":113568412454},{"date":"2021-05-14","current":20.932439,"twenty":18.211382,"median":18.609428,"eighty":18.989722,"marketCap":130304810078},{"date":"2021-05-21","current":21.42584,"twenty":18.222637,"median":18.621479,"eighty":19.15708,"marketCap":133412998209},{"date":"2021-05-28","current":20.903048,"twenty":18.228261,"median":18.63293,"eighty":19.262009,"marketCap":139390283075},{"date":"2021-06-04","current":21.651068,"twenty":18.23616,"median":18.646266,"eighty":19.469543,"marketCap":143693928178},{"date":"2021-06-11","current":22.445258,"twenty":18.254628,"median":18.685372,"eighty":19.921327,"marketCap":148953938860},{"date":"2021-06-18","current":21.103231,"twenty":18.273846,"median":18.713746,"eighty":20.895244,"marketCap":138912100285},{"date":"2021-06-25","current":20.971141,"twenty":18.280883,"median":18.737378,"eighty":20.963401,"marketCap":137955734707},{"date":"2021-07-02","current":20.097632,"twenty":18.294738,"median":18.804429,"eighty":20.971141,"marketCap":131978449841},{"date":"2021-07-09","current":18.514196,"twenty":18.294738,"median":18.79365,"eighty":20.932439,"marketCap":121458428477},{"date":"2021-07-16","current":19.863081,"twenty":18.308817,"median":18.822465,"eighty":20.903048,"marketCap":130304810078},{"date":"2021-07-23","current":19.646294,"twenty":18.311692,"median":18.894417,"eighty":20.899791,"marketCap":128870261710},{"date":"2021-07-30","current":19.035595,"twenty":18.311692,"median":18.896021,"eighty":20.877054,"marketCap":125283890791},{"date":"2021-08-06","current":19.300165,"twenty":18.316487,"median":18.933572,"eighty":20.822682,"marketCap":126718439159},{"date":"2021-08-13","current":19.819393,"twenty":18.355331,"median":18.962395,"eighty":20.562227,"marketCap":130304810078},{"date":"2021-08-20","current":18.489888,"twenty":18.361589,"median":18.967244,"eighty":20.552926,"marketCap":121219337082},{"date":"2021-08-27","current":16.191251,"twenty":18.355331,"median":18.969746,"eighty":20.442475,"marketCap":115122506519},{"date":"2021-09-03","current":16.97458,"twenty":18.294738,"median":18.957896,"eighty":20.41866,"marketCap":120741154293},{"date":"2021-09-10","current":16.41137,"twenty":18.231992,"median":18.926053,"eighty":20.280382,"marketCap":117035237676},{"date":"2021-09-17","current":16.207855,"twenty":18.149015,"median":18.894417,"eighty":20.276168,"marketCap":115242052216},{"date":"2021-09-24","current":15.628978,"twenty":18.057738,"median":18.829722,"eighty":20.133339,"marketCap":111177498507},{"date":"2021-09-30","current":15.643847,"twenty":18.000303,"median":18.798945,"eighty":20.09382,"marketCap":111655681296},{"date":"2021-10-08","current":15.35981,"twenty":17.885628,"median":18.737378,"eighty":20.043519,"marketCap":109623404442},{"date":"2021-10-15","current":14.478875,"twenty":17.760453,"median":18.722142,"eighty":19.99713,"marketCap":103407028181},{"date":"2021-10-22","current":14.491998,"twenty":17.450388,"median":18.685372,"eighty":19.969365,"marketCap":104243848063},{"date":"2021-10-29","current":13.561615,"twenty":16.890605,"median":18.646266,"eighty":19.944976,"marketCap":97310197618},{"date":"2021-11-05","current":13.123478,"twenty":16.600421,"median":18.63293,"eighty":19.898289,"marketCap":94321555185},{"date":"2021-11-12","current":13.599665,"twenty":16.295695,"median":18.621479,"eighty":19.862904,"marketCap":98147017499},{"date":"2021-11-19","current":13.61003,"twenty":16.185159,"median":18.60337,"eighty":19.858576,"marketCap":99222928775},{"date":"2021-11-26","current":13.605676,"twenty":15.887643,"median":18.579712,"eighty":19.845733,"marketCap":99222928775},{"date":"2021-12-03","current":13.734055,"twenty":15.687284,"median":18.515502,"eighty":19.829121,"marketCap":100344348148},{"date":"2021-12-10","current":14.023214,"twenty":15.482761,"median":18.486221,"eighty":19.810549,"marketCap":102631950495},{"date":"2021-12-17","current":13.262477,"twenty":15.278547,"median":18.460445,"eighty":19.789199,"marketCap":96997239221},{"date":"2021-12-24","current":13.346766,"twenty":14.953319,"median":18.429182,"eighty":19.764775,"marketCap":97706927125},{"date":"2021-12-31","current":13.757338,"twenty":14.468756,"median":18.401798,"eighty":19.738201,"marketCap":100931651630},{"date":"2022-01-07","current":14.311176,"twenty":21.065388,"median":33.782204,"eighty":43.14119,"marketCap":104596278126},{"date":"2022-01-14","current":15.608076,"twenty":20.970797,"median":33.782204,"eighty":43.14119,"marketCap":114364951027},{"date":"2022-01-21","current":16.016219,"twenty":20.571969,"median":33.782204,"eighty":43.14119,"marketCap":117581465274},{"date":"2022-01-28","current":14.804515,"twenty":20.165701,"median":33.782204,"eighty":43.14119,"marketCap":108408443161},{"date":"2022-02-04","current":15.576779,"twenty":20.099237,"median":33.785938,"eighty":43.148415,"marketCap":114007560555},{"date":"2022-02-11","current":15.154096,"twenty":20.059018,"median":33.719402,"eighty":43.148415,"marketCap":111148436779},{"date":"2022-02-18","current":15.695706,"twenty":19.951558,"median":33.49601,"eighty":43.148415,"marketCap":115675382757},{"date":"2022-02-25","current":14.899245,"twenty":19.835607,"median":33.250951,"eighty":43.148415,"marketCap":110076265363},{"date":"2022-03-04","current":14.215499,"twenty":19.705691,"median":33.029307,"eighty":43.148415,"marketCap":105072798756},{"date":"2022-03-11","current":13.644778,"twenty":19.453063,"median":32.914672,"eighty":43.148415,"marketCap":100903243250},{"date":"2022-03-18","current":14.208796,"twenty":19.249175,"median":32.76946,"eighty":43.148415,"marketCap":104596278126},{"date":"2022-03-25","current":15.768166,"twenty":19.146441,"median":32.575839,"eighty":43.148415,"marketCap":108527573318},{"date":"2022-04-01","current":15.237229,"twenty":19.035376,"median":32.458858,"eighty":43.148415,"marketCap":105311059070},{"date":"2022-04-08","current":15.10746,"twenty":18.973549,"median":32.382231,"eighty":43.148415,"marketCap":104358017812},{"date":"2022-04-14","current":14.692601,"twenty":18.957896,"median":32.125552,"eighty":43.148415,"marketCap":101379763879},{"date":"2022-04-22","current":14.382825,"twenty":18.897626,"median":31.994991,"eighty":43.148415,"marketCap":98044119474},{"date":"2022-04-29","current":14.539605,"twenty":18.79365,"median":31.946595,"eighty":43.148415,"marketCap":96495427429},{"date":"2022-05-06","current":13.892913,"twenty":18.717104,"median":31.898481,"eighty":43.14119,"marketCap":91849351293},{"date":"2022-05-13","current":14.292236,"twenty":18.646882,"median":31.796092,"eighty":43.148415,"marketCap":92683262394},{"date":"2022-05-20","current":14.361101,"twenty":18.624626,"median":31.752973,"eighty":43.148415,"marketCap":94112824282},{"date":"2022-05-27","current":14.126665,"twenty":18.581916,"median":31.559361,"eighty":43.148415,"marketCap":91134570349},{"date":"2022-06-02","current":13.70929,"twenty":18.516863,"median":31.438351,"eighty":43.14119,"marketCap":89109357675},{"date":"2022-06-10","current":13.591634,"twenty":18.447301,"median":31.198322,"eighty":43.148415,"marketCap":88275446574},{"date":"2022-06-17","current":13.154477,"twenty":18.387006,"median":31.123721,"eighty":43.148415,"marketCap":85297192641},{"date":"2022-06-24","current":14.338493,"twenty":18.355331,"median":30.930113,"eighty":43.148415,"marketCap":93060209106},{"date":"2022-06-30","current":14.312849,"twenty":18.272953,"median":30.881702,"eighty":43.148415,"marketCap":92821898712},{"date":"2022-07-08","current":15.559458,"twenty":18.147586,"median":30.567079,"eighty":43.179913,"marketCap":100924452130},{"date":"2022-07-15","current":15.165385,"twenty":18.04107,"median":30.434355,"eighty":43.179913,"marketCap":97588106605},{"date":"2022-07-22","current":15.561047,"twenty":17.903499,"median":30.152397,"eighty":43.179913,"marketCap":99971210551},{"date":"2022-07-29","current":15.885507,"twenty":17.757385,"median":29.908966,"eighty":43.179913,"marketCap":102354314497},{"date":"2022-08-05","current":15.76104,"twenty":17.551101,"median":29.570511,"eighty":43.179913,"marketCap":101520228116},{"date":"2022-09-15","current":14.791847,"twenty":17.342949,"median":28.954108,"eighty":43.14119,"marketCap":91868657133},{"date":"2022-09-23","current":13.652793,"twenty":17.052938,"median":28.757377,"eighty":43.211411,"marketCap":83408638124},{"date":"2022-09-30","current":15.264906,"twenty":16.848827,"median":28.526462,"eighty":43.211411,"marketCap":92702743514},{"date":"2022-10-07","current":15.015297,"twenty":16.612,"median":28.452547,"eighty":43.010644,"marketCap":91272881147},{"date":"2022-10-14","current":15.848588,"twenty":16.344163,"median":28.283662,"eighty":42.790011,"marketCap":95562468250},{"date":"2022-10-21","current":16.95544,"twenty":16.282168,"median":28.215456,"eighty":42.589254,"marketCap":101639383313},{"date":"2022-10-28","current":16.349189,"twenty":16.282168,"median":27.943949,"eighty":42.068518,"marketCap":97826416999},{"date":"2022-11-04","current":19.049977,"twenty":16.239016,"median":27.814757,"eighty":41.507213,"marketCap":112839971862},{"date":"2022-11-11","current":18.859212,"twenty":16.239016,"median":27.681728,"eighty":41.016607,"marketCap":113078282256},{"date":"2022-11-18","current":19.89556,"twenty":16.239016,"median":27.583564,"eighty":40.496215,"marketCap":119870128503},{"date":"2022-11-25","current":18.291275,"twenty":16.239016,"median":27.441171,"eighty":40.107011,"marketCap":114627299821},{"date":"2022-12-02","current":17.092586,"twenty":16.239016,"median":27.366155,"eighty":39.724046,"marketCap":108312074363},{"date":"2022-12-09","current":15.462387,"twenty":16.148713,"median":27.230987,"eighty":39.499222,"marketCap":99137124170},{"date":"2022-12-16","current":16.016609,"twenty":16.092757,"median":27.113256,"eighty":39.18897,"marketCap":102473469695},{"date":"2022-12-23","current":15.527301,"twenty":15.989748,"median":26.958106,"eighty":39.053352,"marketCap":99494589762},{"date":"2022-12-30","current":15.21108,"twenty":15.950509,"median":26.889426,"eighty":38.753142,"marketCap":97707261802},{"date":"2023-01-06","current":15.953969,"twenty":15.907695,"median":26.614247,"eighty":38.585355,"marketCap":103903332063},{"date":"2023-01-12","current":16.503546,"twenty":15.893579,"median":26.553034,"eighty":38.522311,"marketCap":109265315942},{"date":"2023-01-20","current":16.799288,"twenty":15.891502,"median":26.431542,"eighty":38.194781,"marketCap":111410109494},{"date":"2023-01-27","current":16.930809,"twenty":15.886706,"median":26.382033,"eighty":38.044235,"marketCap":112125040678},{"date":"2023-02-03","current":16.301949,"twenty":15.886706,"median":26.22453,"eighty":37.924275,"marketCap":109027005547},{"date":"2023-02-10","current":15.82141,"twenty":15.858227,"median":26.147405,"eighty":37.582443,"marketCap":105094884036},{"date":"2023-02-17","current":15.879445,"twenty":15.851209,"median":26.089245,"eighty":37.359013,"marketCap":104260797655},{"date":"2023-02-23","current":16.02107,"twenty":15.82141,"median":25.945081,"eighty":37.262491,"marketCap":104618263246},{"date":"2023-03-03","current":16.019413,"twenty":15.792005,"median":25.911057,"eighty":36.977874,"marketCap":104379952852},{"date":"2023-03-10","current":14.443617,"twenty":14.59837,"median":14.828584,"eighty":15.349731,"marketCap":93417674698},{"date":"2023-03-17","current":14.560658,"twenty":15.768867,"median":21.656665,"eighty":28.332193,"marketCap":95085847461},{"date":"2023-03-24","current":12.981848,"twenty":15.731005,"median":21.577454,"eighty":28.167821,"marketCap":91034570752},{"date":"2023-03-31","current":13.207539,"twenty":15.660973,"median":21.503564,"eighty":28.013735,"marketCap":91909763131},{"date":"2023-04-06","current":13.182925,"twenty":15.633339,"median":21.409769,"eighty":27.935966,"marketCap":91679299533},{"date":"2023-04-14","current":13.921512,"twenty":15.580417,"median":21.233565,"eighty":27.805395,"marketCap":96911321815},{"date":"2023-04-21","current":13.512322,"twenty":15.561998,"median":21.163191,"eighty":27.690091,"marketCap":94014461080},{"date":"2023-04-28","current":13.736174,"twenty":15.522366,"median":21.14591,"eighty":27.618743,"marketCap":94860332661},{"date":"2023-05-05","current":13.868352,"twenty":15.464146,"median":21.098914,"eighty":27.586439,"marketCap":95930186037},{"date":"2023-05-12","current":13.289648,"twenty":15.423178,"median":21.023316,"eighty":27.526563,"marketCap":91294154741},{"date":"2023-05-19","current":13.093065,"twenty":15.372148,"median":20.991581,"eighty":27.477906,"marketCap":88678957600},{"date":"2023-05-25","current":12.741824,"twenty":15.354774,"median":20.971141,"eighty":27.44889,"marketCap":85944887862},{"date":"2023-06-02","current":11.994574,"twenty":15.299491,"median":20.908665,"eighty":27.391303,"marketCap":80952238774},{"date":"2023-06-09","current":11.888433,"twenty":15.26174,"median":20.834111,"eighty":27.271203,"marketCap":80120130593},{"date":"2023-06-16","current":12.371007,"twenty":15.219758,"median":20.557576,"eighty":27.18292,"marketCap":82973072929},{"date":"2023-06-23","current":11.850768,"twenty":15.196058,"median":20.45077,"eighty":27.111291,"marketCap":79050277217},{"date":"2023-06-30","current":12.24668,"twenty":15.151398,"median":20.330279,"eighty":27.012147,"marketCap":80952238774},{"date":"2023-07-07","current":11.712044,"twenty":15.057904,"median":20.276168,"eighty":26.892913,"marketCap":77267188258},{"date":"2023-07-14","current":11.372278,"twenty":15.002977,"median":20.15693,"eighty":26.758406,"marketCap":76078462284},{"date":"2023-07-21","current":11.300413,"twenty":14.954126,"median":20.097632,"eighty":26.593388,"marketCap":75246354103},{"date":"2023-07-28","current":11.70569,"twenty":14.888041,"median":20.080031,"eighty":26.551456,"marketCap":77861551244},{"date":"2023-08-04","current":11.026124,"twenty":14.80549,"median":19.975307,"eighty":26.453344,"marketCap":73463265143},{"date":"2023-08-11","current":10.353074,"twenty":14.703988,"median":19.90866,"eighty":26.362381,"marketCap":68589488653},{"date":"2023-08-18","current":10.210866,"twenty":14.647764,"median":19.859614,"eighty":26.286123,"marketCap":67163017485},{"date":"2023-08-25","current":10.517264,"twenty":14.541372,"median":19.787177,"eighty":26.202506,"marketCap":68946106445},{"date":"2023-09-01","current":10.654359,"twenty":14.498231,"median":19.71425,"eighty":26.134784,"marketCap":70134832418},{"date":"2023-09-08","current":10.360995,"twenty":14.466534,"median":19.459989,"eighty":26.037198,"marketCap":67400762680},{"date":"2023-09-15","current":10.645605,"twenty":14.394632,"median":19.354768,"eighty":26.006842,"marketCap":69789171261},{"date":"2023-09-22","current":10.492668,"twenty":14.36435,"median":19.274009,"eighty":25.905275,"marketCap":68485808130},{"date":"2023-09-29","current":10.402214,"twenty":14.323983,"median":19.249175,"eighty":25.803804,"marketCap":68011857901},{"date":"2023-10-06","current":9.808874,"twenty":14.296218,"median":19.207791,"eighty":25.70273,"marketCap":64101768510},{"date":"2023-10-13","current":10.350135,"twenty":14.253552,"median":19.152699,"eighty":25.61328,"marketCap":67537907672},{"date":"2023-10-20","current":10.147872,"twenty":14.176951,"median":19.057429,"eighty":25.5592,"marketCap":66116056984},{"date":"2023-10-27","current":12.117175,"twenty":14.12429,"median":19.013299,"eighty":25.462022,"marketCap":78912713175},{"date":"2023-11-03","current":12.575022,"twenty":14.100631,"median":18.972248,"eighty":25.348997,"marketCap":82111877222},{"date":"2023-11-10","current":12.396154,"twenty":14.067238,"median":18.9504,"eighty":25.275729,"marketCap":80927001649},{"date":"2023-11-17","current":12.321328,"twenty":14.023197,"median":18.901757,"eighty":25.194476,"marketCap":81163976764},{"date":"2023-11-24","current":12.399124,"twenty":13.984647,"median":18.859212,"eighty":25.120405,"marketCap":82348852337},{"date":"2023-12-01","current":12.666921,"twenty":13.926892,"median":18.79365,"eighty":25.006628,"marketCap":84837091041},{"date":"2023-12-08","current":11.776885,"twenty":13.882604,"median":18.713746,"eighty":24.983683,"marketCap":78557250503},{"date":"2023-12-15","current":12.451032,"twenty":13.817707,"median":18.663991,"eighty":24.983683,"marketCap":83533727910},{"date":"2023-12-22","current":12.141243,"twenty":13.743549,"median":18.628854,"eighty":24.983683,"marketCap":81400951878},{"date":"2023-12-29","current":12.762436,"twenty":13.726966,"median":18.618332,"eighty":24.983683,"marketCap":86021966614},{"date":"2024-01-05","current":12.693748,"twenty":13.689451,"median":18.581916,"eighty":24.983683,"marketCap":84955578598},{"date":"2024-01-12","current":11.572237,"twenty":13.640836,"median":18.489888,"eighty":24.983683,"marketCap":77490862487},{"date":"2024-01-19","current":10.471864,"twenty":13.603168,"median":18.436013,"eighty":24.983683,"marketCap":70026146376},{"date":"2024-01-26","current":10.655084,"twenty":13.577463,"median":18.387006,"eighty":24.983683,"marketCap":70974046834},{"date":"2024-02-02","current":10.383713,"twenty":13.536146,"median":18.361589,"eighty":24.977272,"marketCap":69078245917},{"date":"2024-02-09","current":10.385996,"twenty":13.504604,"median":18.310254,"eighty":24.975258,"marketCap":69433708589},{"date":"2024-02-16","current":11.003942,"twenty":13.479368,"median":18.275186,"eighty":24.943852,"marketCap":73580773095},{"date":"2024-02-23","current":11.258208,"twenty":13.441056,"median":18.20909,"eighty":24.933755,"marketCap":74884136226},{"date":"2024-03-01","current":10.859535,"twenty":13.396243,"median":18.138731,"eighty":24.933622,"marketCap":72277409965},{"date":"2024-03-08","current":10.587789,"twenty":13.360072,"median":18.007351,"eighty":24.854907,"marketCap":70500096605},{"date":"2024-03-15","current":11.932947,"twenty":13.337069,"median":17.921371,"eighty":24.830405,"marketCap":79386663404},{"date":"2024-03-22","current":11.940445,"twenty":13.293778,"median":17.771736,"eighty":24.789936,"marketCap":76187499356},{"date":"2024-03-28","current":11.461235,"twenty":13.256241,"median":17.753644,"eighty":24.729621,"marketCap":72869847751},{"date":"2024-04-05","current":11.464682,"twenty":13.233727,"median":17.650391,"eighty":24.679307,"marketCap":72869847751},{"date":"2024-04-12","current":11.066922,"twenty":13.166487,"median":17.433876,"eighty":24.534346,"marketCap":70381609048},{"date":"2024-04-19","current":10.762555,"twenty":13.133439,"median":17.337025,"eighty":24.438,"marketCap":68387515573},{"date":"2024-04-26","current":12.31799,"twenty":13.098481,"median":17.092586,"eighty":24.351453,"marketCap":78174569431},{"date":"2024-05-03","current":12.625335,"twenty":13.019816,"median":16.986159,"eighty":24.272043,"marketCap":80069710508},{"date":"2024-05-10","current":12.781755,"twenty":12.950119,"median":16.877035,"eighty":24.217908,"marketCap":81254173681},{"date":"2024-05-17","current":12.352711,"twenty":12.790512,"median":16.692548,"eighty":24.162827,"marketCap":78411462065},{"date":"2024-05-24","current":11.950832,"twenty":12.698085,"median":16.588843,"eighty":24.141207,"marketCap":75687196767},{"date":"2024-05-31","current":12.010793,"twenty":12.671877,"median":16.503546,"eighty":24.141207,"marketCap":78529908383},{"date":"2024-06-07","current":12.733102,"twenty":12.628637,"median":16.401723,"eighty":24.141207,"marketCap":83149314758},{"date":"2024-06-14","current":12.381679,"twenty":12.578344,"median":16.335057,"eighty":24.141207,"marketCap":80780388412},{"date":"2024-06-21","current":11.534389,"twenty":12.550156,"median":16.277517,"eighty":24.141207,"marketCap":75094965180},{"date":"2024-06-28","current":11.286026,"twenty":12.502744,"median":16.181097,"eighty":24.141207,"marketCap":73447512373},{"date":"2024-07-05","current":11.324775,"twenty":12.462333,"median":16.135519,"eighty":24.141207,"marketCap":73683678007},{"date":"2024-07-12","current":11.199432,"twenty":12.424412,"median":16.051711,"eighty":24.141207,"marketCap":72975181103},{"date":"2024-07-19","current":10.909275,"twenty":12.39853,"median":16.016609,"eighty":24.141207,"marketCap":71085856026},{"date":"2024-07-26","current":10.507803,"twenty":12.38014,"median":15.959528,"eighty":24.141207,"marketCap":68724199680},{"date":"2024-08-02","current":10.387473,"twenty":12.350889,"median":15.919026,"eighty":24.141207,"marketCap":67897619959},{"date":"2024-08-09","current":10.534048,"twenty":12.320216,"median":15.879445,"eighty":24.141207,"marketCap":69314613766},{"date":"2024-08-16","current":10.942544,"twenty":12.254585,"median":15.848588,"eighty":24.141207,"marketCap":72030518565},{"date":"2024-08-23","current":8.612773,"twenty":12.24036,"median":15.787253,"eighty":24.111183,"marketCap":55706439375},{"date":"2024-08-30","current":8.707324,"twenty":12.184858,"median":15.768166,"eighty":23.868625,"marketCap":56696077748},{"date":"2024-09-06","current":8.57512,"twenty":12.156613,"median":15.728261,"eighty":23.708284,"marketCap":55862146061},{"date":"2024-09-13","current":8.224895,"twenty":12.140314,"median":15.652511,"eighty":23.654426,"marketCap":53440368639},{"date":"2024-09-20","current":8.897683,"twenty":12.116016,"median":15.610301,"eighty":23.557671,"marketCap":58158424710},{"date":"2024-09-27","current":10.014304,"twenty":12.036675,"median":15.572703,"eighty":23.354636,"marketCap":65850721365},{"date":"2024-10-04","current":12.125415,"twenty":11.998034,"median":15.543857,"eighty":23.180469,"marketCap":79370515486},{"date":"2024-10-10","current":12.522013,"twenty":11.993963,"median":15.521132,"eighty":22.932388,"marketCap":81468414574},{"date":"2024-10-18","current":11.836043,"twenty":11.946677,"median":15.456675,"eighty":22.633104,"marketCap":76573316703},{"date":"2024-10-25","current":11.224235,"twenty":11.886171,"median":15.41735,"eighty":22.359254,"marketCap":72610618426},{"date":"2024-11-01","current":9.488262,"twenty":11.847475,"median":15.362763,"eighty":22.154915,"marketCap":61421823291},{"date":"2024-11-08","current":9.705837,"twenty":11.817498,"median":15.341996,"eighty":22.053423,"marketCap":62354222886},{"date":"2024-11-15","current":9.377592,"twenty":11.73035,"median":15.276218,"eighty":21.861008,"marketCap":59790124001},{"date":"2024-11-22","current":10.69469,"twenty":11.706646,"median":15.239437,"eighty":21.597887,"marketCap":59294758503},{"date":"2024-11-29","current":10.637842,"twenty":11.645107,"median":15.208439,"eighty":21.293327,"marketCap":58946025105},{"date":"2024-12-06","current":10.494754,"twenty":11.580576,"median":15.154395,"eighty":21.104177,"marketCap":58016174660},{"date":"2024-12-13","current":10.11463,"twenty":11.535402,"median":15.08382,"eighty":21.008407,"marketCap":55863848313},{"date":"2024-12-20","current":10.191651,"twenty":11.480965,"median":15.014412,"eighty":20.901094,"marketCap":55980231330},{"date":"2024-12-27","current":10.10034,"twenty":11.463447,"median":14.983596,"eighty":20.695634,"marketCap":55435643374},{"date":"2025-01-03","current":9.689376,"twenty":11.445377,"median":14.927097,"eighty":20.443418,"marketCap":53232134537},{"date":"2025-01-10","current":9.260048,"twenty":11.389145,"median":14.884576,"eighty":20.277854,"marketCap":50680703252},{"date":"2025-01-17","current":9.240109,"twenty":11.331005,"median":14.798181,"eighty":20.098501,"marketCap":50612385700},{"date":"2025-01-24","current":9.22431,"twenty":11.30042,"median":14.691248,"eighty":20.08134,"marketCap":50842441999},{"date":"2025-01-28","current":9.263558,"twenty":11.285659,"median":14.668991,"eighty":20.06341,"marketCap":51302554596},{"date":"2025-02-07","current":9.499859,"twenty":11.238006,"median":14.548439,"eighty":19.939639,"marketCap":52337807940},{"date":"2025-02-14","current":10.04582,"twenty":11.192801,"median":14.50033,"eighty":19.862904,"marketCap":55213511673},{"date":"2025-02-21","current":10.428132,"twenty":11.156217,"median":14.467766,"eighty":19.810549,"marketCap":57629102809},{"date":"2025-02-28","current":9.83611,"twenty":11.08007,"median":14.407172,"eighty":19.681932,"marketCap":54178258329},{"date":"2025-03-07","current":10.087975,"twenty":11.041857,"median":14.369224,"eighty":19.381518,"marketCap":55788652420},{"date":"2025-03-14","current":10.042721,"twenty":10.996508,"median":14.325772,"eighty":19.277408,"marketCap":55558596121},{"date":"2025-03-21","current":10.088267,"twenty":10.9434,"median":14.287921,"eighty":19.247416,"marketCap":55788652420},{"date":"2025-03-28","current":10.54642,"twenty":10.917922,"median":14.229327,"eighty":19.151447,"marketCap":58204243555},{"date":"2025-04-03","current":13.728141,"twenty":10.917922,"median":14.175438,"eighty":19.059642,"marketCap":63610566573},{"date":"2025-04-11","current":13.200839,"twenty":10.917922,"median":14.119619,"eighty":19.012307,"marketCap":60619834691},{"date":"2025-04-17","current":13.878058,"twenty":10.919757,"median":14.105388,"eighty":18.982556,"marketCap":63814149021},{"date":"2025-04-25","current":15.221403,"twenty":10.916088,"median":14.100709,"eighty":18.957896,"marketCap":70126699734},{"date":"2025-05-02","current":15.372424,"twenty":10.917922,"median":14.103048,"eighty":18.915856,"marketCap":70973002827},{"date":"2025-05-09","current":14.109918,"twenty":10.916088,"median":14.100579,"eighty":18.894417,"marketCap":65601455109},{"date":"2025-05-16","current":14.361314,"twenty":10.916088,"median":14.069574,"eighty":18.815208,"marketCap":67315778849},{"date":"2025-05-23","current":16.093101,"twenty":10.916088,"median":14.069574,"eighty":18.731203,"marketCap":75658821049},{"date":"2025-05-30","current":20.235393,"twenty":10.916088,"median":14.069574,"eighty":18.685372,"marketCap":92573481949},{"date":"2025-06-06","current":22.077697,"twenty":10.916088,"median":14.069574,"eighty":18.685372,"marketCap":101259388897},{"date":"2025-06-13","current":22.019154,"twenty":10.916088,"median":14.069574,"eighty":18.685372,"marketCap":101030812398},{"date":"2025-06-20","current":19.017586,"twenty":10.916088,"median":14.069574,"eighty":18.685372,"marketCap":87087645981},{"date":"2025-06-27","current":19.239928,"twenty":10.917922,"median":14.078162,"eighty":18.693874,"marketCap":88352546724},{"date":"2025-07-04","current":20.284352,"twenty":10.917922,"median":14.078162,"eighty":18.693874,"marketCap":93153073195},{"date":"2025-07-11","current":19.781614,"twenty":10.917922,"median":14.078162,"eighty":18.693874,"marketCap":90752809960},{"date":"2025-07-18","current":22.913805,"twenty":10.917922,"median":14.078162,"eighty":18.693874,"marketCap":105040091125},{"date":"2025-07-25","current":21.445568,"twenty":10.917922,"median":14.078162,"eighty":18.693874,"marketCap":98667005163},{"date":"2025-08-01","current":24.729474,"twenty":10.917922,"median":14.078162,"eighty":18.693874,"marketCap":113072616577},{"date":"2025-08-08","current":25.590627,"twenty":10.917922,"median":14.078162,"eighty":18.693874,"marketCap":117302835802},{"date":"2025-08-15","current":27.377599,"twenty":10.917922,"median":14.078162,"eighty":18.693874,"marketCap":125305953254},{"date":"2025-08-22","current":26.336106,"twenty":10.917922,"median":14.078162,"eighty":18.693874,"marketCap":120161092035},{"date":"2025-08-29","current":27.312947,"twenty":10.917922,"median":14.078162,"eighty":18.693874,"marketCap":115130561065},{"date":"2025-09-05","current":30.38084,"twenty":10.917922,"median":14.078162,"eighty":18.693874,"marketCap":127935548989},{"date":"2025-09-12","current":28.049747,"twenty":10.917922,"median":14.078162,"eighty":18.693874,"marketCap":118331808046},{"date":"2025-09-19","current":26.957728,"twenty":10.917922,"median":14.078162,"eighty":18.693874,"marketCap":113644267824},{"date":"2025-09-26","current":24.716619,"twenty":10.917922,"median":14.078162,"eighty":18.693874,"marketCap":103926196631},{"date":"2025-09-30","current":25.423422,"twenty":10.917922,"median":14.078162,"eighty":18.693874,"marketCap":107127443612}],"updateTime":1759289441058},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01093\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2571323935","title":"石药集团(01093)：石药创新建议于联交所主板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2571323935","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571323935?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 21:25","pubTimestamp":1759238741,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团(01093)公布，于2025年9月30日，公司间接非全资附属公司石药创新董事会已批准于联交所主板的H股建议上市。预期紧随H股建议上市完成后，石药创新将仍为公司的间接附属公司。假设紧随H股建议上市完成后石药创新经扩大已发行股本的10%将获发行及超额配股权获悉数行使，石药创新根据H股建议上市发行及配发发售股份，将导致公司于石药创新的股权百分比减少约8.46%，而紧随H股建议上市完成后，公司将持有石药创新约66.20%股权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1351525.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1226288170.HKD","LU1951186391.HKD","SG9999004220.SGD","IE00BZ08YS42.EUR","BK1515","LU1008478684.HKD","IE00B543WZ88.USD","LU2039709279.SGD","LU1813983027.USD","IE00BZ08YT58.USD","LU0501845795.SGD","LU1226287529.USD","LU1152091754.HKD","LU1807302812.USD","LU0072913022.USD","BK1521","LU0880133367.SGD","LU0326950275.SGD","IE0008369823.USD","LU1960683339.HKD","LU1328277881.USD","LU0140636845.USD","IE00BZ08YR35.GBP","LU0315179316.USD","LU1226287875.USD","IE00B031HY20.USD","LU1152091168.USD","LU1993786604.SGD","LU0314109678.HKD","LU0067412154.USD","LU1226288253.USD","01093","BK1191","IE00B5MMRT66.SGD","IE0008368742.USD","LU1226287792.SGD"],"gpt_icon":0},{"id":"2571466943","title":"石药创新拟11亿元收购巨石生物29%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2571466943","media":"中金财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571466943?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 18:24","pubTimestamp":1759227845,"startTime":"0","endTime":"0","summary":"中访网数据  石药创新制药股份有限公司9月30日公告，公司与控股股东石药集团恩必普药业有限公司签署协议，拟以现金11亿元收购其持有的控股子公司石药集团巨石生物制药有限公司29%股权。交易完成后，石药创新对巨石生物的持股比例将从51%提升至80%。此次交易定价以评估机构出具的评估报告为依据，标的公司股东全部权益评估值为38.05亿元。巨石生物是一家专注于抗体类药物、ADC及mRNA疫苗等领域的创新生物医药企业，其恩朗苏拜单抗注射液与注射用奥马珠单抗已于2024年上市。公司表示，此次收购旨在深化在创新生物医药领域的战略布局，提升综合竞争力。该事项已获董事会审议通过，尚需股东大会批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20250930/31685492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU0880133367.SGD","LU1226288170.HKD","IE0008368742.USD","SG9999004220.SGD","LU0314109678.HKD","IE0008369823.USD","LU0326950275.SGD","LU1813983027.USD","LU1008478684.HKD","LU2039709279.SGD","IE00B543WZ88.USD","LU1960683339.HKD","LU1226287529.USD","LU1226288253.USD","LU0501845795.SGD","BK1191","LU0315179316.USD","IE00BZ08YR35.GBP","LU1328277881.USD","IE00B031HY20.USD","LU1152091168.USD","LU1226287792.SGD","IE00B5MMRT66.SGD","01093","LU1226287875.USD","LU1152091754.HKD","LU1807302812.USD","LU1951186391.HKD","LU0140636845.USD","IE00BZ08YS42.EUR","LU0072913022.USD","BK1521","LU0067412154.USD","LU1993786604.SGD","IE00BZ08YT58.USD","BK1515"],"gpt_icon":0},{"id":"2571348951","title":"石药集团(01093)：SYH2070注射液(双链小干扰RNA药物)在中国获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2571348951","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571348951?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 17:30","pubTimestamp":1759224612,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，集团自主研发的化学1类新药SYH2070注射液(该产品)已获得中华人民共和国国家药品监督管理局批准，可在中国开展临床试验。临床前研究显示，该产品在药物活性和药效持续性方面均优于同类型siRNA产品，展现出药物作用效果持久、安全性良好、患者依从性高等差异化优势，具有较高的临床开发价值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1351303.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","LU0880133367.SGD","LU1152091168.USD","IE00BZ08YT58.USD","LU1008478684.HKD","LU1152091754.HKD","LU0072913022.USD","RNA","BK1515","LU1226287875.USD","IE00BZ08YS42.EUR","LU0315179316.USD","LU1226287792.SGD","SG9999004220.SGD","LU0501845795.SGD","LU1226288253.USD","LU1328277881.USD","IE0008369823.USD","LU1226288170.HKD","LU1807302812.USD","IE0008368742.USD","LU1993786604.SGD","LU1951186391.HKD","BK4139","IE00B5MMRT66.SGD","BK1521","LU1960683339.HKD","LU0326950275.SGD","BK4505","LU1813983027.USD","LU1226287529.USD","LU0067412154.USD","IE00B543WZ88.USD","LU0314109678.HKD","LU2039709279.SGD","LU0140636845.USD","BK1191","BK4585","01093","IE00BZ08YR35.GBP","IE00B031HY20.USD"],"gpt_icon":0},{"id":"2571069399","title":"《大行》瑞银降石药(01093.HK)和科伦药业(002422.SZ)至“中性”行业首选改为翰森制药(03692.HK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2571069399","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571069399?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 10:44","pubTimestamp":1759200240,"startTime":"0","endTime":"0","summary":"基于基本面疲弱，将石药和科伦药业评级降至“中性”，并将行业首选从三生制药更换为翰森制药，因其稳定的传统业务和创新的管线储备。长期管线潜力方面，该行认为恒瑞及翰森制药表现最佳。预计石药和科伦药业在2024-2034年的收入复合年增长率最低，仅为三生制药、翰森制药和信达生物13%平均水平的一半。科伦药业面临需求疲弱和激烈竞争，可能导致其2025年收入增长在同行中最低。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180202161550760_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180202161550760_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1473859/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2148510915.USD","BK1191","LU0315179316.USD","LU0326950275.SGD","LU2039709279.SGD","LU1813983027.USD","03692","LU1226287792.SGD","IE00BZ08YT58.USD","LU1008478684.HKD","BK1521","LU1226288253.USD","IE00B543WZ88.USD","LU0140636845.USD","LU1979443071.USD","LU1993786604.SGD","LU1064130708.USD","IE00BZ08YS42.EUR","IE00B031HY20.USD","LU1960683339.HKD","LU0501845795.SGD","LU0880133367.SGD","SG9999004220.SGD","IE0008368742.USD","LU1152091754.HKD","BK1589","BK1515","BK0060","LU1226288170.HKD","IE00BZ08YR35.GBP","002422","LU1934453819.USD","BK1583","LU1951186391.HKD","BK0239","LU1226287529.USD","LU1328277881.USD","LU0067412154.USD","LU1152091168.USD","01093","LU0072913022.USD","LU0314109678.HKD","IE0008369823.USD","LU1064131003.USD","LU1807302812.USD","IE00B5MMRT66.SGD","LU1226287875.USD"],"gpt_icon":0},{"id":"2571800933","title":"大健康行业周报 |13亿，“中国美敦力”完成交割；东星医疗：拟以支付现金方式购买武汉医佳宝90%的股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2571800933","media":"保观","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571800933?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 12:04","pubTimestamp":1759118650,"startTime":"0","endTime":"0","summary":"保观 |聚焦保险创新国内篇行业动态13亿，“中国美敦力”完成交割近日，上海生物医药并购基金携手浦东创投集团旗下引领区基金，完成收购日本大冢集团所持微创医疗股份的交割，交易金额达13亿元人民币，上海生物医药并购基金成为微创医疗重要战略股东，持股约7.3%。此次交割完成后，被视为“中国美敦力”的微创医疗股价在港股市场表现活跃，市值突破200亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929123929a44b6c21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929123929a44b6c21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","LU0326950275.SGD","BK1191","LU0588546209.SGD","LU0067412154.USD","LU1960683339.HKD","BK1500","LU1993786604.SGD","LU0315179316.USD","LU1328277881.USD","LU1719994722.HKD","LU1226287529.USD","LU1303224171.USD","IE00B543WZ88.USD","SG9999004220.SGD","BK1570","01276","03692","BK1197","LU1226287792.SGD","IE00B031HY20.USD","IE0008369823.USD","BK1515","LU0359201885.HKD","LU1251922891.USD","00874","IE0008368742.USD","00570","LU0072913022.USD","02196","01093","LU1008478684.HKD","LU2039709279.SGD","LU1023057109.AUD","LU1226288170.HKD","LU1226288253.USD","LU2543165471.USD","LU2328871848.SGD","LU1152091168.USD","LU1152091754.HKD","LU1226287875.USD","03320","06160","LU1969619763.USD","IE00B5MMRT66.SGD","01177","SBHMY","BK1606","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1593"],"gpt_icon":0},{"id":"2571782687","title":"华源证券-医药行业周报信立泰：全面布局CKM管线，创新出海加速推进-250928","url":"https://stock-news.laohu8.com/highlight/detail?id=2571782687","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571782687?lang=zh_cn&edition=fundamental","pubTime":"2025-09-28 23:02","pubTimestamp":1759071720,"startTime":"0","endTime":"0","summary":"全面布局CKM管线，创新出海加速推进。我们认为信立泰创新研发已经迎来重大蜕变，公司全面布局心血管-肾脏-代谢慢病领域，在研管线涵盖高血压、血脂异常、心衰、代谢、肾科等多个领域，并布局单抗、多抗、ADC、多肽、环肽、基因编辑等新型技术平台，多款产品已经进入到临床阶段，不断强化公司在中国慢病领域综合性龙头地位。我们看好信立泰基于心血管为核心的CKM创新管线布局，带动公司成长为中国综合性慢病领域创新药龙头。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092900142997af3c80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092900142997af3c80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","06978","01276","LU0140636845.USD","LU1008478684.HKD","SG9999004220.SGD","SBHMY","LU0501845795.SGD","LU0067412154.USD","BK1521","01177","BK1574","LU0359201612.USD","BK1583","IE00B5MMRT66.SGD","LU1328277881.USD","LU1226287792.SGD","IE00B543WZ88.USD","LU1226288170.HKD","IE00BZ08YS42.EUR","LU1960683339.HKD","LU0315179316.USD","LU1226288253.USD","LU0072913022.USD","LU2039709279.SGD","BK1589","IE00B031HY20.USD","LU0314109678.HKD","LU0326950275.SGD","01093","IE0008369823.USD","03692","LU1951186391.HKD","LU0359202008.SGD","LU1023057109.AUD","LU1226287529.USD","09926","LU2543165471.USD","BK1161","LU1152091754.HKD","LU1226287875.USD","LU1807302812.USD","IE00BZ08YT58.USD","LU0880133367.SGD","BK1191","IE00BZ08YR35.GBP","LU1152091168.USD","IE0008368742.USD","LU0359201885.HKD","LU1813983027.USD","LU1993786604.SGD"],"gpt_icon":0},{"id":"2571872826","title":"石药在谋变","url":"https://stock-news.laohu8.com/highlight/detail?id=2571872826","media":"药智网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571872826?lang=zh_cn&edition=fundamental","pubTime":"2025-09-28 15:55","pubTimestamp":1759046149,"startTime":"0","endTime":"0","summary":"今年以来，石药集团药物研发与对外合作动作频频，正在加速转型。该药物瞄准帕金森这一未被满足的临床需求，承载着石药在神经领域的期望。2025年上半年财报显示，石药神经系统药物收入为37.55亿元，同比下滑28.3%。石药已在财报中明确表示，要建立“行业领先的AI药物发现技术平台”。但无论ALMB-0166最终能否成功，石药集团在创新之路上的持续投入与战略调整，已显示出石药加码创新的的决心。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250928155951a449ab25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250928155951a449ab25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","LU1226287875.USD","LU0067412154.USD","LU1328277881.USD","LU1226288170.HKD","IE00B5MMRT66.SGD","LU1226287792.SGD","LU1993786604.SGD","LU2039709279.SGD","IE0008368742.USD","LU1226288253.USD","LU1807302812.USD","IE0008369823.USD","LU0315179316.USD","LU1226287529.USD","LU1152091168.USD","SG9999004220.SGD","LU0314109678.HKD","LU1152091754.HKD","IE00BZ08YR35.GBP","IE00B031HY20.USD","LU0880133367.SGD","BK1521","LU0140636845.USD","LU1813983027.USD","IE00BZ08YT58.USD","01093","IE00BZ08YS42.EUR","LU0326950275.SGD","LU1951186391.HKD","IE00B543WZ88.USD","LU1008478684.HKD","LU0501845795.SGD","LU1960683339.HKD","LU0072913022.USD"],"gpt_icon":0},{"id":"2570819174","title":"石药集团加速蜕变","url":"https://stock-news.laohu8.com/highlight/detail?id=2570819174","media":"米内网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570819174?lang=zh_cn&edition=fundamental","pubTime":"2025-09-28 08:10","pubTimestamp":1759018232,"startTime":"0","endTime":"0","summary":"精彩内容今年以来，石药集团喜讯不断：10个品种获批上市，10款1类新药首次获批临床，达成4项重磅BD交易等。独家新药销售大涨9月18日，石药集团发布2025年中期报告，报告期内公司实现收入总额132.73亿元，归母净利润25.48亿元。今年以来，石药集团已达成4项重磅BD合作，总金额高达97.1亿美元。石药集团有权收取1.2亿美元的预付款、最高可达19.55亿美元的潜在开发、监管及商业里程碑付款等。2025年6月，石药集团与阿斯利康达成战略研究合","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250928082133a6a2ef00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250928082133a6a2ef00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0140636845.USD","LU1226287529.USD","LU1951186391.HKD","01093","IE00BZ08YS42.EUR","LU1152091754.HKD","LU1807302812.USD","BK1521","LU0067412154.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","IE0008368742.USD","LU1008478684.HKD","LU1226288253.USD","LU0326950275.SGD","LU0880133367.SGD","LU2039709279.SGD","IE00BZ08YT58.USD","LU1993786604.SGD","LU1328277881.USD","LU0501845795.SGD","BK1191","LU1960683339.HKD","LU0072913022.USD","BK1515","LU1226287792.SGD","LU1226288170.HKD","LU0314109678.HKD","SG9999004220.SGD","IE00B031HY20.USD","LU1152091168.USD","IE00BZ08YR35.GBP","LU1226287875.USD","IE0008369823.USD","LU1813983027.USD","LU0315179316.USD"],"gpt_icon":0},{"id":"2570907071","title":"开源证券：小核酸药物有望成为减重赛道新风口 联用GLP-1或多重满足临床需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2570907071","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570907071?lang=zh_cn&edition=fundamental","pubTime":"2025-09-26 14:20","pubTimestamp":1758867619,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，开源证券发布研报称，小核酸药物布局减重适应症主要围绕INHBE和ALK7两个靶点。小核酸药物联用GLP-1，有望解决多重未满足临床需求临床前大鼠数据显示，Arrowhead的ALK7siRNA分子联用Tirzepatide可以进一步提升减重效果的同时，还有望带来更持久的疗效，从而实现更长间隔的给药。这提示INHBE/ALK7通路在脂肪分布而非单纯体重调控中起着关键作用。风险提示创新药研发热度下滑、药物临床研发失败、药物安全性风险等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01093","LU0880133367.SGD","01276","LU1226288253.USD","LU0315179316.USD","LU1152091754.HKD","LU0140636845.USD","BK4144","LU0501845795.SGD","LU0072913022.USD","IE00BZ08YT58.USD","IE0008368742.USD","BK1521","LU0359201612.USD","LU2543165471.USD","LU1328277881.USD","LU0067412154.USD","BK1515","IE00B543WZ88.USD","LU1807302812.USD","LU1226288170.HKD","SG9999004220.SGD","LU0314109678.HKD","LU0326950275.SGD","LU1008478684.HKD","LU0359202008.SGD","IE00B5MMRT66.SGD","LU0359201885.HKD","IE0008369823.USD","GLP","LU2039709279.SGD","LU1960683339.HKD","LU1813983027.USD","LU1226287792.SGD","LU1226287875.USD","IE00B031HY20.USD","BK1191","BK4590","IE00BZ08YR35.GBP","LU1226287529.USD","161027","LU1152091168.USD","LU1993786604.SGD","IE00BZ08YS42.EUR","LU1023057109.AUD","LU1951186391.HKD"],"gpt_icon":0},{"id":"2570026976","title":"【券商聚焦】交银国际：政策端持续释放利好信号 医药行业格局优化趋势明确","url":"https://stock-news.laohu8.com/highlight/detail?id=2570026976","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570026976?lang=zh_cn&edition=fundamental","pubTime":"2025-09-26 08:50","pubTimestamp":1758847809,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，本周恒生医疗保健指数跌1.4%，跑输大市。其中，互联网医药、CXO及中药板块表现较优于其他板块。本周，内资关注补涨机会，外资亦加仓长期潜力大、当前性价比较高的创新药标的，及潜在受益于降息周期的CXO企业。整体来看，政策端持续释放利好信号，行业格局优化趋势明确。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/ODYzMTA4NTI1Nzg5MjIw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODYzMTA4NTI1Nzg5MjIw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1966876","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2778985437.USD","01093","BK1587","LU0516423174.USD","01276","02268","LU1152091754.HKD","LU2399975544.HKD","09926","02096","01177","LU0708995583.HKD","LU1328277881.USD","LU1242518857.USD","03692","LU1807302812.USD","LU2476274720.SGD","HK0000320264.USD","01801","LU1303224171.USD","06160","LU0314109678.HKD","LU0634319403.HKD","LU1008478684.HKD","LU0359202008.SGD","06078","IE00B5MMRT66.SGD","03329","IE0008369823.USD","LU1961090484.USD","LU1770034418.SGD","LU2097828631.EUR","06990","00013","01548","02273","BK1574","LU1969619763.USD","LU0737861772.HKD","02269","BK1191","LU0516422440.USD","LU0572944931.SGD","LU2097828714.EUR","LU0039217434.USD","BK1209","09995","02162","LU1880383366.USD","01530"],"gpt_icon":1},{"id":"2570102616","title":"石药进军AD百亿蓝海，直指卫材/渤健！恒瑞、先声等群雄逐鹿","url":"https://stock-news.laohu8.com/highlight/detail?id=2570102616","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570102616?lang=zh_cn&edition=fundamental","pubTime":"2025-09-25 19:45","pubTimestamp":1758800733,"startTime":"0","endTime":"0","summary":"此前，卫材/渤健与礼来的市场争夺战一度焦灼，未来还将迎来石药集团等国产选手的竞逐。AD治疗新纪元石药发力破局原研AD是一种常见的退行性神经疾病，其发病率随年龄增长而显著上升。截至目前，仑卡奈单抗尚未被纳入国家医保目录，仍属于自费药物。此次获批使仑卡奈单抗成为目前首款可在家中使用自动注射器进行皮下给药的AD治疗药物，整个注射过程平均仅需约15秒。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250925195233a69d9b31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250925195233a69d9b31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1521","LU0359201885.HKD","LU0359201612.USD","LU1008478684.HKD","LU1226287792.SGD","LU2543165471.USD","LU0072913022.USD","SG9999004220.SGD","01276","LU2039709279.SGD","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","IE0008368742.USD","LU1226288170.HKD","LU0315179316.USD","LU1951186391.HKD","LU1226287875.USD","LU0326950275.SGD","LU1152091168.USD","BK1191","BK1515","IE00B543WZ88.USD","LU1023057109.AUD","LU1226287529.USD","LU1807302812.USD","IE00BZ08YR35.GBP","LU0314109678.HKD","LU1813983027.USD","IE00B031HY20.USD","LU1960683339.HKD","LU0501845795.SGD","LU1226288253.USD","LU0067412154.USD","LU0359202008.SGD","IE0008369823.USD","LU0880133367.SGD","LU1993786604.SGD","LU1328277881.USD","LU1152091754.HKD","LU0140636845.USD","IE00B5MMRT66.SGD","01093"],"gpt_icon":0},{"id":"2570095229","title":"石药集团(01093)：仑卡奈单抗注射液在中国获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2570095229","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570095229?lang=zh_cn&edition=fundamental","pubTime":"2025-09-25 18:29","pubTimestamp":1758796151,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团(01093)公布，该集团开发的仑卡奈单抗注射液已获中华人民共和国国家药品监督管理局批准，可在中国开展临床试验，为国内首个获得临床许可的仑卡奈单抗注射液生物类似药。该产品是一种重组抗人β淀粉样蛋白单克隆抗体，为乐意保®的生物类似药，按照治疗用生物制品3.3类申报，适用于治疗由阿尔茨海默病引起的轻度认知障碍和阿尔茨海默病轻度痴呆。该产品的研发遵循生物类似药相关研究指南。药学及非临床研究结果显示，该产品与原研参照药在质量、安全性和有效性方面高度相似，支持开展后续临床研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349452.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石药集团(01093)：仑卡奈单抗注射液在中国获临床试验批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1152091754.HKD","LU1226288170.HKD","SG9999004220.SGD","LU0072913022.USD","IE00BZ08YS42.EUR","BK1521","IE0008369823.USD","IE00B031HY20.USD","LU1813983027.USD","LU0314109678.HKD","IE00B5MMRT66.SGD","LU2039709279.SGD","LU0067412154.USD","LU0140636845.USD","LU0315179316.USD","BK1515","LU1008478684.HKD","BK1191","LU1807302812.USD","LU0326950275.SGD","LU1993786604.SGD","LU1152091168.USD","IE00BZ08YT58.USD","LU1226287875.USD","LU1951186391.HKD","LU1960683339.HKD","LU1328277881.USD","LU1226288253.USD","LU1226287529.USD","LU0501845795.SGD","IE00B543WZ88.USD","IE0008368742.USD","LU0880133367.SGD","IE00BZ08YR35.GBP","LU1226287792.SGD","01093"],"gpt_icon":0},{"id":"2569773900","title":"东吴证券：MNC纷纷下注小核酸领域 中国企业有望抢占全球蓝海市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2569773900","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569773900?lang=zh_cn&edition=fundamental","pubTime":"2025-09-24 15:02","pubTimestamp":1758697325,"startTime":"0","endTime":"0","summary":"近期，全球范围内小核酸药物再起风云，进入BD高潮，诺华、AZ、渤健等纷纷下注小核酸领域，我国靖因药业、苏州瑞博生物等药企也取得交易进展，当前小核酸上市品种相对较少，中国企业有望抢占全球蓝海市场。当前小核酸上市品种相对较少，中国企业有望抢占全球蓝海市场截至2025年中，全球共获批上市22款，包括13款ASO药物、7款siRNA药物、2款核酸适配体药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1348865.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BZ08YR35.GBP","BK1521","IE0008368742.USD","LU2039709279.SGD","LU1226288253.USD","LU1951186391.HKD","LU1152091168.USD","IE0008369823.USD","LU0501845795.SGD","LU1807302812.USD","LU1226287529.USD","IE00B031HY20.USD","BK0276","LU0314109678.HKD","02137","601555","BK0188","BK1574","BK0012","01093","LU0880133367.SGD","LU0067412154.USD","LU1152091754.HKD","LU1226287875.USD","LU1328277881.USD","BK1515","IE00BZ08YS42.EUR","LU0326950275.SGD","BK1191","IE00B543WZ88.USD","LU1813983027.USD","BK1161","LU1008478684.HKD","LU1226288170.HKD","LU1993786604.SGD","BK1587","IE00B5MMRT66.SGD","LU0072913022.USD","BK0028","BK0009","LU1226287792.SGD","IE00BZ08YT58.USD","LU0315179316.USD","LU0140636845.USD","BK0183","LU1960683339.HKD","SG9999004220.SGD"],"gpt_icon":0},{"id":"2569683817","title":"中邮·医药|周观点：基药目录调整工作有望继续推进，关注中药品种调增机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2569683817","media":"中邮证券研究所","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569683817?lang=zh_cn&edition=fundamental","pubTime":"2025-09-23 09:01","pubTimestamp":1758589265,"startTime":"0","endTime":"0","summary":"l本周主题基药目录调整工作受到关注。1基药目录调整工作有望继续推进，关注中药品种调增机会基药目录调整工作受到关注。现行《国家基本药物目录》已执行7年，国家基本药物目录调整周期原则上不超过3年，国家基药目录调整工作有望继续推进。“986”原则有望推动基药目录品种快速放量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923091944a7305bb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923091944a7305bb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09926","02616","01877","BK1574","01801","03759","01093","01530","06978","09606","01276","02157","02359","BK1161","02162"],"gpt_icon":1},{"id":"2569752496","title":"石药集团美洛昔康纳晶注射液破局而生","url":"https://stock-news.laohu8.com/highlight/detail?id=2569752496","media":"石药集团","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569752496?lang=zh_cn&edition=fundamental","pubTime":"2025-09-23 08:44","pubTimestamp":1758588289,"startTime":"0","endTime":"0","summary":"美洛昔康纳晶注射液作为全球首款FDA长效静脉非甾体药物，曾凭借纳米晶技术带来突破，却因商业原因一度退市，令人扼腕。石药集团凭借领先的纳米晶技术平台，突破产业化壁垒，成功研发美洛昔康注射液（Ⅲ）（美洛泰），实现从“0到1”的国内独家突破。石药美洛昔康注射液（Ⅲ）不仅是一次技术突破，更是一场疼痛治疗的效率突破。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923085904a43d627f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923085904a43d627f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1152091754.HKD","LU1807302812.USD","LU1993786604.SGD","LU1152091168.USD","IE00BZ08YS42.EUR","LU0067412154.USD","LU1008478684.HKD","BK1515","LU1226287529.USD","LU1226287875.USD","LU1813983027.USD","LU1960683339.HKD","IE00B031HY20.USD","LU1226288170.HKD","01093","IE00BZ08YR35.GBP","LU2039709279.SGD","IE0008368742.USD","BK1191","IE00B543WZ88.USD","LU0880133367.SGD","LU0314109678.HKD","LU1226287792.SGD","IE0008369823.USD","LU1951186391.HKD","LU0326950275.SGD","IE00BZ08YT58.USD","LU0315179316.USD","LU0140636845.USD","IE00B5MMRT66.SGD","LU0072913022.USD","LU1328277881.USD","LU0501845795.SGD","SG9999004220.SGD","LU1226288253.USD","BK1521"],"gpt_icon":0},{"id":"2569878999","title":"年内收益率翻倍基金达40只：都有哪些产品？买了啥？","url":"https://stock-news.laohu8.com/highlight/detail?id=2569878999","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569878999?lang=zh_cn&edition=fundamental","pubTime":"2025-09-22 16:35","pubTimestamp":1758530108,"startTime":"0","endTime":"0","summary":"另外，全市场年内收益率为负的基金数量已不足1000只。截至19日，永赢科技智选今年以来的累计收益率约为196.53%，成为年内收益率最高的基金。该基金还是任桀从业以来管理的首只产品。截至19日，汇添富香港优势精选今年以来的累计收益率约为170.95%，基金经理为张韡。另外，年内累计收益率在50%至100%的公募基金共计有846只，除了重仓AI、创新药板块的基金外，还有部分重仓人形机器人产业的产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922163725953d6f35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922163725953d6f35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","01093","06990","01801","00013","BK1191","BK1161","06978","09969","BK1574","09606","BK1588"],"gpt_icon":0},{"id":"2569173594","title":"每日卖空追踪 | 石药集团 09月22日卖空量成交946.8万股，卖空比例为7.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569173594","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569173594?lang=zh_cn&edition=fundamental","pubTime":"2025-09-22 16:30","pubTimestamp":1758529819,"startTime":"0","endTime":"0","summary":"石药集团北京时间09月22日，股价较前一交易日持平，卖空量成交946.8万股，较上一交易日减少48.13%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922163159a72ef299&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922163159a72ef299&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0140636845.USD","01093","BK1521","LU1226288170.HKD","IE00BZ08YT58.USD","LU1807302812.USD","IE00BZ08YR35.GBP","IE00B031HY20.USD","LU0315179316.USD","LU1226287875.USD","IE0008369823.USD","LU0501845795.SGD","LU1226287529.USD","LU1960683339.HKD","BK1191","LU1152091754.HKD","LU1993786604.SGD","LU1813983027.USD","IE00BZ08YS42.EUR","IE00B543WZ88.USD","LU0880133367.SGD","LU1008478684.HKD","LU1226288253.USD","LU1226287792.SGD","BK1515","IE0008368742.USD","LU2039709279.SGD","SG9999004220.SGD","LU0072913022.USD","LU1328277881.USD","LU1152091168.USD","LU1951186391.HKD","IE00B5MMRT66.SGD","LU0067412154.USD","LU0314109678.HKD","LU0326950275.SGD"],"gpt_icon":0},{"id":"2569359787","title":"石药集团09月22日主力净流入5654.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2569359787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569359787?lang=zh_cn&edition=fundamental","pubTime":"2025-09-22 16:15","pubTimestamp":1758528959,"startTime":"0","endTime":"0","summary":"09月22日，石药集团股价收平报9.94元，成交金额12.4亿元，换手率1.08%，振幅4.12%，量比0.76。石药集团今日主力资金净流入5654.5万元，上一交易日主力净流出1594.3万元。该股近5个交易日下跌6.45%，主力资金累计净流出984.8万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入9262.1万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092216233197a1f8ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092216233197a1f8ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226287875.USD","LU0067412154.USD","LU1152091754.HKD","LU1813983027.USD","LU1807302812.USD","01093","LU1226287792.SGD","LU2039709279.SGD","LU0314109678.HKD","BK1515","LU1226288253.USD","IE00B5MMRT66.SGD","LU0501845795.SGD","IE0008368742.USD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","IE0008369823.USD","IE00BZ08YT58.USD","IE00B031HY20.USD","BK1191","LU0140636845.USD","LU1328277881.USD","BK1521","LU0326950275.SGD","LU1152091168.USD","LU1960683339.HKD","LU0880133367.SGD","LU0072913022.USD","LU1951186391.HKD","LU1008478684.HKD","LU0315179316.USD","LU1226287529.USD","LU1226288170.HKD","LU1993786604.SGD","SG9999004220.SGD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"2569889927","title":"医药生物行业点评报告：集采优化叠加创新驱动，Pharma迎来发展新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2569889927","media":"开源证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569889927?lang=zh_cn&edition=fundamental","pubTime":"2025-09-22 16:08","pubTimestamp":1758528487,"startTime":"0","endTime":"0","summary":"Pharma2025H1业绩稳健，创新出海助力估值重塑创新转型进入收获期，头部Pharma业绩稳健增长。集采优化叠加商保助力，Pharma有望长周期受益8月28日国家医保局发布《关于公布通过2025年国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整形式审查的申报药品名单的公告》。9月20日，国家医保局发布第十一批国家组织药品集中采购文件，进一步明确优化价差控制“锚点”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922160816a43be594&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922160816a43be594&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","09969","06990","00013","06978","BK1574","BK1161","02096","03933","01093","01801","BK1191","01276"],"gpt_icon":0},{"id":"2569926735","title":"丁苯酞市场风云：石药创新领航，复星等企业突围前景几何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2569926735","media":"摩熵医药大数据","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569926735?lang=zh_cn&edition=fundamental","pubTime":"2025-09-22 14:59","pubTimestamp":1758524364,"startTime":"0","endTime":"0","summary":"截至目前，已有14家企业登记了丁苯酞仿制BE试验，其中不乏华海、科伦、美迪西、仙琚等行业大企业。小结石药集团凭借丁苯酞在脑卒中治疗领域筑牢市场壁垒，复星医药等众多企业的突围尝试均铩羽而归，凸显出丁苯酞仿制与改良之路阻碍重重，参比未定、临床方案不明、专利限制三重难题交织。在丁苯酞仿制困局待解之时，石药以创新优势稳步领航医药市场，未来丁苯酞仿制格局及企业突围前景，值得持续关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922150615a72ebdc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922150615a72ebdc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0326950275.SGD","LU1813983027.USD","LU1807302812.USD","IE00BZ08YS42.EUR","BK1515","LU1960683339.HKD","LU1226287529.USD","LU1008478684.HKD","BK1521","LU0880133367.SGD","01093","LU0315179316.USD","LU2039709279.SGD","LU1226288253.USD","LU1152091754.HKD","LU0501845795.SGD","LU0314109678.HKD","LU1328277881.USD","IE00BZ08YR35.GBP","IE00B5MMRT66.SGD","IE0008369823.USD","IE00B031HY20.USD","LU0072913022.USD","IE0008368742.USD","LU1951186391.HKD","BK1191","LU1152091168.USD","LU0140636845.USD","LU1226287875.USD","SG9999004220.SGD","IE00B543WZ88.USD","LU0067412154.USD","IE00BZ08YT58.USD","LU1993786604.SGD","LU1226287792.SGD","LU1226288170.HKD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":194,"code":"91000000","status":"200"}]}}